Purdue execs seek to overturn disbarment

Corporate Counsel reports that Howard Udell, the former general counsel of OxyContin maker Purdue Pharma LP, has had his lawsuit regarding his debarment consolidated with the cases of two of his fellow executives caught up in the OxyContin fraudulent marketing scandal. Udell, former chief executive Michael Friedman and former chief medical officer Paul D. Goldenheim are seeking to overturn an order excluding them from participation in federal health care programs for 12 years. The move comes in the wake of their guilty pleas in a $634.5 million settlement over the company’s marketing of OxyContin. In their lawsuit, the former executives say the record of conviction contains no evidence that they themselves committed any unlawful acts. Rather, they claim, “throughout their careers, each of the plaintiffs has demonstrated an unwavering commitment to combating abuse and diversion of prescription drugs.”


View the original complaint in the case here.

About Erin Marie Daly

I’m a freelance journalist based in San Francisco. My book on prescription drug and heroin addiction was published in August 2014 by Counterpoint Press.
This entry was posted in Crime, Litigation and tagged , . Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *